NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Intelligent Bio Solutions logo
$1.41 -0.10 (-6.56%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$1.45 +0.04 (+2.76%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Advanced

Key Stats

Today's Range
$1.37
▼
$1.62
50-Day Range
$1.41
▼
$2.29
52-Week Range
$1.35
▼
$24.90
Volume
95,901 shs
Average Volume
40,960 shs
Market Capitalization
$4.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Intelligent Bio Solutions Inc. is a medical technology company focused on non-invasive testing and diagnostic solutions. Its flagship offering is the Intelligent Fingerprinting Drug Screening System, which analyzes trace sweat collected from a person’s fingertips to screen for drugs.

The system combines a portable reader with single-use fingerprint test cartridges. Its compact format is designed for use in settings such as workplaces, law enforcement, drug treatment and rehabilitation programs, and other organizations that conduct screening.

The company adopted its current name after acquiring UK-based Intelligent Fingerprinting in 2023. Its fingerprint testing technology is developed and commercialized through operations serving customers in multiple markets.

AI Generated. May Contain Errors.

Intelligent Bio Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

INBS MarketRank™: 
1.20130773511 of 5 stars

Intelligent Bio Solutions scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Intelligent Bio Solutions has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Intelligent Bio Solutions has only been the subject of 1 research reports in the past 90 days.

  • Read more about Intelligent Bio Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($5.18) to ($4.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Intelligent Bio Solutions is -0.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Intelligent Bio Solutions is -0.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Intelligent Bio Solutions has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.97% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 3.08, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently decreased by 30.26%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Intelligent Bio Solutions does not currently pay a dividend.

  • Dividend Growth

    Intelligent Bio Solutions does not have a long track record of dividend growth.

  • News Sentiment

    Intelligent Bio Solutions has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • Insider Buying vs. Insider Selling

    In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.76% of the stock of Intelligent Bio Solutions is held by insiders.

  • Percentage Held by Institutions

    32.97% of the stock of Intelligent Bio Solutions is held by institutions.

  • Read more about Intelligent Bio Solutions' insider trading history.
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INBS Stock News Headlines

Seven bucks, yours for life: my Black Friday indicator deal
Base Camp Trading's Thomas Wood is giving away his proprietary Snapback Indicator for just $7 this Black Friday. Others paid $500 for it. It's a one-time price with no recurring billing, and the indicator is yours for life. It shows when it's time to sell or go short, and when it makes sense to buy. Check it for a potential Snapback before your next trade.tc pixel
Intelligent Bio Solutions (INBS) Set to Announce Earnings on Wednesday
See More Headlines

INBS Stock Analysis - Frequently Asked Questions

Intelligent Bio Solutions' stock was trading at $9.53 at the beginning of 2026. Since then, INBS shares have decreased by 85.2% and is now trading at $1.4110.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its quarterly earnings data on Tuesday, November, 10th. The company reported ($0.86) EPS for the quarter, topping the consensus estimate of ($1.31) by $0.45. The company had revenue of $1.39 million for the quarter, compared to the consensus estimate of $1.40 million. Intelligent Bio Solutions had a negative net margin of 269.28% and a negative trailing twelve-month return on equity of 150.00%.

Intelligent Bio Solutions's stock reverse split before market open on Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Intelligent Bio Solutions (INBS) raised $22 million in an IPO on Wednesday, December 23rd 2020. The company issued 1,270,589 shares at a price of $16.00-$18.00 per share.

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include NVIDIA (NVDA), Quantum Computing (QUBT), SNDL (SNDL), Energy Fuels (UUUU), Energy Transfer (ET), Salesforce (CRM) and Aeva Technologies (AEVA).

Company Calendar

Last Earnings
11/10/2026
Today
11/21/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:INBS
Previous Symbol
NASDAQ:GBS
CIK
1725430
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.43 million
Net Margins
-269.28%
Pretax Margin
-270.06%
Return on Equity
-150.00%
Return on Assets
-83.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.98
Quick Ratio
1.87

Sales & Book Value

Annual Sales
$4.22 million
Price / Sales
1.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.22 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
3,320,000
Free Float
3,225,000
Market Cap
$4.68 million
Optionable
Not Optionable
Beta
4.48
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:INBS) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners